You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 3, January 21, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System, Other
 •Dermatology
 •Dermatologic Disorders
 •Pediatrics
 •Adolescent Medicine
 •Cardiovascular System
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Adverse Effects
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Allopurinol and the Role of Uric Acid in Hypertension—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: The purpose of our study was to investigate the role of uric acid in the pathogenesis of essential hypertension. As described in the article, it was predicated on numerous studies showing that an elevated uric acid level predicts the development of hypertension in the general population, the presence of hyperuricemia in 90% of adolescents with newly diagnosed essential hypertension, and the finding that raising uric acid causes hypertension in animals. Our short-term study resulted in normal blood pressure in 86% of hypertensive participants when their uric acid level was lowered to less than 5.0 mg/dL vs 3% when they received placebo treatment. (To convert uric acid to µmol/L, multiply by 59.485.)

The selection of allopurinol as the drug to lower uric acid was based on its efficacy, simplicity of administration, a well-established adverse effect profile that we could monitor, and a lack of better alternatives. The purpose of . . . [Full Text of this Article]

Daniel I. Feig, MD, PhD
dfeig@bcm.tmc.edu
Department of Pediatrics
Baylor College of Medicine
Houston, Texas

Richard J. Johnson, MD
Department of Medicine
University of Florida School of Medicine
Gainesville



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial
Daniel I. Feig, Beth Soletsky, and Richard J. Johnson
JAMA. 2008;300(8):924-932.
ABSTRACT | FULL TEXT  

RELATED LETTER

Allopurinol and the Role of Uric Acid in Hypertension
Allen D. Brinker
JAMA. 2009;301(3):270.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.